Terms and Conditions

Introduction

By using Next Inject you confirm your acceptance of, and agree to be bound by, these terms and conditions.

Agreement to Terms and Conditions

This Agreement takes effect on the date on which you first use the Next Inject application.

Unlimited Access Software License with Termination Rights

The Next Inject Software License facilitates the acquisition of Next Inject software through single or multiple purchases, granting users unrestricted and perpetual access to its comprehensive individual functionalities.

Tailored for independent creators, software developers, entrepreneurs, and small businesses, Next Inject empowers users to create compelling web applications and online portfolios.

This license entails a straightforward and flexible arrangement, exempting users from recurring fees or subscriptions. However, it is important to acknowledge that the licensor retains the right to terminate the license without conditions or prerequisites.

This termination provision enables the licensor to exercise control over software distribution and utilization.

Opting for any Next Inject Software Licenses enables users to enjoy the benefits of the software while recognizing the licensor's unrestricted termination rights, which provide adaptability and address potential unforeseen circumstances.

Refunds

Due to the nature of digital products, Next Inject plugins cannot be refunded or exchanged once access is granted.

However, there may be special cases in which a refund can be disputed privately. In this case contact the software author directly.

Disclaimer

It is not warranted that Next Inject will meet your requirements or that its operation will be uninterrupted or error free.

All express and implied warranties or conditions not stated in this Agreement (including without limitation, loss of profits, loss or corruption of data, business interruption or loss of contracts), so far as such exclusion or disclaimer is permitted under the applicable law are excluded and expressly disclaimed.

This Agreement does not affect your statutory rights.

Warranties and Limitation of Liability

Next Inject does not give any warranty, guarantee or other term as to the quality, fitness for purpose or otherwise of the software.

Next Inject shall not be liable to you by reason of any representation (unless fraudulent), or any implied warranty, condition or other term, or any duty at common law, for any loss of profit or any indirect, special or consequential loss, damage, costs, expenses or other claims (whether caused by Next Inject's negligence or the negligence of its servants or agents or otherwise) which arise out of or in connection with the provision of any goods or services by Next Inject.

Next Inject shall not be liable or deemed to be in breach of contract by reason of any delay in performing, or failure to perform, any of its obligations if the delay or failure was due to any cause beyond its reasonable control.

Notwithstanding contrary clauses in this Agreement, in the event that Next Inject are deemed liable to you for breach of this Agreement, you agree that Next Inject's liability is limited to the amount actually paid by you for your services or software, which amount calculated in reliance upon this clause.

You hereby release Next Inject from any and all obligations, liabilities and claims in excess of this limitation.

Responsibilities

Next Inject is not responsible for what the user does with the user-generated content.

Price Adjustments

As we continue to improve Next Inject and expand our offerings, individual pricing may fluctuate.

General Terms and Law

This Agreement is governed by the laws of the United Kingdom.

You acknowledge that no joint venture, partnership, employment, or agency relationship exists between you and Next Inject as a result of your use of these services.

You agree not to hold yourself out as a representative, agent or employee of Next Inject.

You agree that Next Inject will not be liable by reason of any representation, act or omission to act by you.

Last updated: 28 July 2024.